TNXP
Tonix Pharmaceuticals Holding Corp
NASDAQ
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||||
| Capital Expenditures | 3.4M | 120,000 | 7.9M | 48.1M | 35.3M | 8.6M | 17,000 | 6,000 | 5,000 | 66,000 | 36,000 | 2,764 | 34,279 |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||||
| Free Cash Flow | -103.2M | -61.0M | -109.9M | -146.2M | -110.9M | -57.1M | -26.7M | -24.0M | -19.1M | -37.4M | -5.7M | -2.6M | -1.3M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — |